Detalhe da pesquisa
1.
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
PLoS Biol
; 20(2): e3001531, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143473
2.
Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022.
Emerg Infect Dis
; 29(4): 723-733, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848869
3.
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions.
Sci Transl Med
; 14(645): eabm2311, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35348368
4.
SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection - A multistage national household survey and modelling study, Dominican Republic, June-October 2021.
Lancet Reg Health Am
; 16: 100390, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408529
5.
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles.
bioRxiv
; 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494026
6.
Epidemiological and Immunological Features of Obesity and SARS-CoV-2.
Viruses
; 13(11)2021 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835041
7.
Tracking immune correlates of protection for emerging SARS-CoV-2 variants.
Lancet Infect Dis
; 23(2): 153-154, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640795